Mannucci P, Siboni S
Res Pract Thromb Haemost. 2024; 8(2):102369.
PMID: 38595335
PMC: 11002306.
DOI: 10.1016/j.rpth.2024.102369.
Candy V, Whitworth H, Grabell J, Thibeault L, Harpell L, Bowman M
Blood Adv. 2018; 2(20):2629-2636.
PMID: 30327371
PMC: 6199650.
DOI: 10.1182/bloodadvances.2018023713.
Mannucci P
Haematologica. 2018; 103(3):379-381.
PMID: 29491128
PMC: 5830372.
DOI: 10.3324/haematol.2018.187567.
Jin L, Ji H
Chin Med J (Engl). 2015; 128(5):644-7.
PMID: 25698197
PMC: 4834776.
DOI: 10.4103/0366-6999.151663.
Crowley M, Crowely M, Quinn S, Coleman E, Eustace J, Gilligan O
J Thromb Thrombolysis. 2014; 39(2):245-9.
PMID: 25271000
DOI: 10.1007/s11239-014-1140-z.
Endometrial haemostasis and menstruation.
Davies J, Kadir R
Rev Endocr Metab Disord. 2012; 13(4):289-99.
PMID: 23180227
DOI: 10.1007/s11154-012-9226-4.
Evidence-based recommendations on the treatment of von Willebrand disease in Italy.
Mannucci P, Franchini M, Castaman G, Federici A
Blood Transfus. 2009; 7(2):117-26.
PMID: 19503633
PMC: 2689066.
DOI: 10.2450/2008.0052-08.
Prophylaxis of bleeding episodes in patients with von Willebrand's disease.
Federici A
Blood Transfus. 2008; 6 Suppl 2:s26-32.
PMID: 19105507
PMC: 2652221.
DOI: 10.2450/2008.0034-08.
Self-treatment with desmopressin intranasal spray in patients with bleeding disorders: effect on bleeding symptoms and socioeconomic factors.
Lethagen S, Tennvall G
Ann Hematol. 1993; 66(5):257-60.
PMID: 8507721
DOI: 10.1007/BF01738476.
Impaired fibrinolysis in the hemolytic-uremic syndrome of childhood.
Menzel D, Levi M, Dooijewaard G, Peters M, Ten Cate J
Ann Hematol. 1994; 68(1):43-8.
PMID: 8110878
DOI: 10.1007/BF01695919.
Desmopressin (DDAVP) and hemostasis.
Lethagen S
Ann Hematol. 1994; 69(4):173-80.
PMID: 7948303
DOI: 10.1007/BF02215950.
Pharmacokinetics and haematological effects of desmopressin.
Kohler M, Harris A
Eur J Clin Pharmacol. 1988; 35(3):281-5.
PMID: 3141199
DOI: 10.1007/BF00558266.
Fibrinolytic response to standardized venous occlusion in different age groups.
Hong S, Pyo S, Kim M, Kim S, Park I, Oh D
Korean J Intern Med. 1989; 4(1):48-53.
PMID: 2487404
PMC: 4534964.
DOI: 10.3904/kjim.1989.4.1.48.
The use of vasopressin in the treatment of upper gastrointestinal haemorrhage.
Stump D, Hardin T
Drugs. 1990; 39(1):38-53.
PMID: 2178911
DOI: 10.2165/00003495-199039010-00004.
Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I.
Lethagen S, Harris A, Nilsson I
Blut. 1990; 60(3):187-91.
PMID: 2107887
DOI: 10.1007/BF01720274.
A variant of nephrogenic diabetes insipidus: V2 receptor abnormality restricted to the kidney.
Knoers N, Monnens L
Eur J Pediatr. 1991; 150(5):370-3.
PMID: 1828422
DOI: 10.1007/BF01955943.
Nephrogenic diabetes insipidus: clinical symptoms, pathogenesis, genetics and treatment.
Knoers N, Monnens L
Pediatr Nephrol. 1992; 6(5):476-82.
PMID: 1457333
DOI: 10.1007/BF00874020.
Evidence for intact V1-vasopressin receptors in congenital nephrogenic diabetes insipidus.
Knoers N, Janssens P, Goertz J, Monnens L
Eur J Pediatr. 1992; 151(5):381-3.
PMID: 1396896
DOI: 10.1007/BF02113263.
